ƒy[ƒ^[Eƒqƒ…[ƒuƒi[ • ƒ}ƒCƒNƒEƒ~ƒ…[ƒWƒbƒNŒค‹†Š
ƒƒfƒBƒJƒ‹EƒŒƒ]ƒiƒ“ƒXEƒZƒ‰ƒs[Eƒ~ƒ…[ƒWƒbƒN®
ธ_“IEถ—“I‚ศƒXƒgƒŒƒXว๓‚ฬŒyŒธ

SCIENTIFIC RESEARCH

Research Fields in Detail

Gynecology

Menstruation Cycle

Vacuum Aspiration

Vacuum Aspiration

Vacuum Aspiration

OPH Syndrome

Operation

OPH-Syndrome

Kariopicnotic Index

Blood Pressure

Blood Pressure

Risk Characteristics

Hormone Status

Fetal Heart Activity

Somatic Disorders

Calming of the Fetus

Immune Status

Faster Recovery

Faster Recovery

States of Mind

States of Mind

Anxiety

Contractions

Cortisol

Stress

Anodyne Drugs

Headaches

Headache Attacks

Sleep

OPH Syndrome

Sleep

Sleep Disorders

Reduction of Pain

Stress

Cortisol

 

 






Improvement of the Hormone Status in Pregnant Women with Somatic Disorders in the Last Month of Pregnancy



The pregnant women were sent to hospital, because the fetuses were in danger due to rheumatism and heart, kidney and liver prob­lems of the mothers. All women received a conventional medical drug therapy as well as a treatment with physiotherapeutic exercises.

Information about the well being of the fetus was derived by the levels of placenta-lac­to­gen in blood plasma as well of estriol in the urine of the mother. These hormone levels were measured before starting with the treat­ment and at the end of the treatment.


Medical Resonance Therapy Music® Group

In addition to the conventional drug therapy 15 women listened after physiotherapeutic ex­er­cises for seven days one hour to relaxing music preparations of Medical Resonance Therapy Music® via cd-player and headphone.

Together with the conventional treatment the Medical Resonance Therapy Music® improved the hormone status very clearly:
the level of placenta-lactogen rose from 217.5 nmol/l (± 5.3) to 274.9 nmol/l (± 5.7) and the estriol level from 80.0 µmol/24 hours (±2) to 103.3 µmol/24 hours (±1.7), which clearly demonstrates a positive effect of the Medical Resonance Therapy Music® on the function of the fetal-placental unit and through this on the well-being of the pregnant woman and her fetus.
Control Group


In this group 10 pregnant women received the conventional treatment only.

The hormone levels changed merely: pla­cen­ta­lac­to­gen went down from 203.9 nmol/l (±3,6) before the treatment to 203.5 nmol/l (±5.1) after ending the therapy, and parallel to this estriol dropped from 77.1 µmol/24 hours (±1.8) to 75.8 µmol/24 hours (±2). Here the conventional treatment alone did not create an increase in the well-being of the pregnant and her fetus.










 

Investigators:

Prof. Dr. med. A. Reznikov
Dr. med. I. Stepanenko
Dr. med. D. Sutkovoy




With kind permission of AAR EDITION INTERNATIONAL
© 1998- SCIENTIFIC MUSIC MEDICINE | Contact

Subject to change in the interests of scientific advancement.